News - Page 260 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Beckley Psytech Reveals Scientific Advisory Board Consisting of Renowned Psychedelic Experts

Beckley Psytech Reveals Scientific Advisory Board Consisting of Renowned Psychedelic Experts

Post published:August 18, 2020
Post category:Press Release

Read more about the article CBS 60 Minutes Brings Psychedelic Medicine to the Masses

CBS 60 Minutes Brings Psychedelic Medicine to the Masses

Post published:August 17, 2020
Post category:News

Read more about the article Medical Marijuana as Precedent for Psychedelic Medicine; and the Role of Pharmacists

Medical Marijuana as Precedent for Psychedelic Medicine; and the Role of Pharmacists

Post published:August 14, 2020
Post category:Editorial

Read more about the article New Psychedelic Research Nonprofit Teams with Johns Hopkins University for Real-World Study on Use of Psilocybin Mushrooms

New Psychedelic Research Nonprofit Teams with Johns Hopkins University for Real-World Study on Use of Psilocybin Mushrooms

Post published:August 14, 2020
Post category:Press Release

Read more about the article Revive Therapeutics Signs MOU with Attwill Medical Solutions for Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Signs MOU with Attwill Medical Solutions for Phase 3 Clinical Trial for Bucillamine in COVID-19

Post published:August 14, 2020
Post category:Press Release

Read more about the article Mind Medicine (MindMed) Inc. Announces Q2 2020 Financial Results

Mind Medicine (MindMed) Inc. Announces Q2 2020 Financial Results

Post published:August 14, 2020
Post category:Press Release

Read more about the article Mota Ventures to Change Name to Thoughtful Brands Inc. (CSE: TBI)

Mota Ventures to Change Name to Thoughtful Brands Inc. (CSE: TBI)

Post published:August 13, 2020
Post category:Press Release

Read more about the article Tryp Therapeutics Partners with Albany Molecular Research Inc. to Manufacture a Proprietary Psilocybin-based Drug

Tryp Therapeutics Partners with Albany Molecular Research Inc. to Manufacture a Proprietary Psilocybin-based Drug

Post published:August 13, 2020
Post category:Press Release

Read more about the article Mydecine Innovations Group Featured in Forbes for the First-Of-Its-Kind Clinicals Using Psilocybin Therapy For PTSD

Mydecine Innovations Group Featured in Forbes for the First-Of-Its-Kind Clinicals Using Psilocybin Therapy For PTSD

Post published:August 13, 2020
Post category:Press Release

Read more about the article MindMed Expanding R&D in Europe, Appoints Dr. Miri Halperin Wernli As President

MindMed Expanding R&D in Europe, Appoints Dr. Miri Halperin Wernli As President

Post published:August 13, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.